The MLL Munich Leukemia Laboratory: a portrait

„When a sample arrives at the MLL, it enters a world of extensive automation and digitization”, writes Leah Lawrence in the Clinical News of the American Society of Hematology (ASH). With an innovative spirit of the times and state-of-the-art methods such as artificial intelligence, the team around Prof. Dr. Claudia Haferlach, Prof. Dr. Dr. Torsten Haferlach and Prof. Dr. Wolfgang Kern works every day to advance leukemia diagnostics in order to provide patients worldwide with the best possible therapy. Now ASH has interviewed the MLL heads and presents the MLL Munich Leukemia Laboratory in its Clinical News.